Literature DB >> 29030221

Inhibition of BDNF production by MPP+ through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.

Shan Zhang1, Shu Chen2, Anmin Liu3, Jungang Wan1, Lingwen Tang1, Niandong Zheng2, Yi Xiong4.   

Abstract

The neurotrophin brain-derived neurotrophic factor (BDNF) has been involved in supporting of neuron survival. The observation of reduced level of BDNF in the substantia nigra (SN) of Parkinson's disease (PD) patients suggests its important role in neuron protection in PD pathogenesis. However, the mechanism underlying the down-regulation of BDNF in PD was largely unknown. In this study, we found that miR-210-3p is involved in the regulation of BDNF production by 1-methyl-4-phenylpyridinium (MPP+). MPP+ inhibits the BDNF production in SH-SY5Y cells through a transcription independent manner. Moreover, miR-210-3p, which targets BDNF mRNA, is up-regulated by MPP+ in SH-SY5Y cells. Importantly, inhibition of miR-210-3p prevents the reduction of BDNF production by MPP+ and improves the DA neuron survival in 1-methyl-4-phenyl-1,2,3,6-tetra hydropyridine (MPTP) model. Together, we demonstrated up-regulation of miR-210-3p by MPP+ reduces the BDNF production and contributes to the DA neuron damage.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  BDNF; MPP(+); Neuron damage; Parkinson’s disease; miR-210-3p

Mesh:

Substances:

Year:  2017        PMID: 29030221     DOI: 10.1016/j.neulet.2017.10.014

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Acanthopanax senticosus Protects Structure and Function of Mesencephalic Mitochondria in A Mouse Model of Parkinson's Disease.

Authors:  Shu-Min Liu; Xu-Zhao Li; Shuai-Nan Zhang; Zhi-Ming Yang; Ke-Xin Wang; Fang Lu; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Chin J Integr Med       Date:  2018-08-08       Impact factor: 1.978

2.  Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5.

Authors:  Changjun He; Xue Bai; Yingbin Li; Haobo Sun; Xianglong Kong; Bicheng Fu; Lantao Chen; Kaibin Zhu; Pengju Li; Shidong Xu
Journal:  Cell Cycle       Date:  2019-10-25       Impact factor: 4.534

3.  MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure.

Authors:  Chiara Costa; Michele Teodoro; Carmela Alessandra Rugolo; Carmela Alibrando; Federica Giambò; Giusi Briguglio; Concettina Fenga
Journal:  Toxicol Rep       Date:  2020-05-21

4.  Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways.

Authors:  Michelle E Watts; Sarah M Williams; Jess Nithianantharajah; Charles Claudianos
Journal:  Noncoding RNA       Date:  2018-03-27

Review 5.  MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer.

Authors:  Jakub Godlewski; Jacek Lenart; Elzbieta Salinska
Journal:  Noncoding RNA       Date:  2019-02-23

Review 6.  Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson's and Alzheimer's Diseases.

Authors:  Laura Thomas; Tullio Florio; Carolina Perez-Castro
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

Review 7.  A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.

Authors:  Sara Abdolahi; Ameneh Zare-Chahoki; Farshid Noorbakhsh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2022-08-02       Impact factor: 5.682

Review 8.  MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.

Authors:  Sushmaa Chandralekha Selvakumar; K Auxzilia Preethi; Deusdedit Tusubira; Durairaj Sekar
Journal:  Front Cell Neurosci       Date:  2022-09-16       Impact factor: 6.147

Review 9.  The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.